期刊文献+

分化型甲状腺癌手术治疗方法的探讨 被引量:3

Surgery methods of differentiated thyroid cancer
原文传递
导出
摘要 目的探讨分化型甲状腺癌的手术治疗方法。方法对照组分化型甲状腺癌的患者给予外科手术治疗;研究组分化型甲状腺癌患者手术方法同对照组,术后加用I联合治疗,记录两组分化型甲状腺癌患者治疗后临床疗效。结果分化型甲状腺癌患者经不同方法治疗后,研究组临床治疗总有效率高达92.86%,显著高于对照组临床治疗总有效率(71.43%),差异有统计学意义(P〈0.05)。结论分化型甲状腺癌主要采用外科手术治疗,术后根据患者实际情况联合I及甲状腺激素替代治疗可显著提高其临床疗效,保障患者生活质量及降低病死率。 Objective To investigaste the surgery treatment of differentiated thyroid cancer. Methods In the control group, patients were treated by differentiated thyroid cancer surgery; In the study group, patients were treated by the surgery method as the contrd group, plus combination therapy with I. The clinical efficacy of the two groups were compared. Results In the study group, the total efficiency was up to 92.86%, which was significantly higher than the total efficiency of control group(71.43% ), there was significant difference (P 〈 0.05). Conclusions Differentiated thyroid cancer mainly adopts surgical treatment, postoperative joint , I and thyroid hormone replacement therapy can significantly improve its clinical efficacy, protect the quality of lire of patients and reduce mortality in patients according to the actual situation.
出处 《中国实用医刊》 2015年第15期72-73,共2页 Chinese Journal of Practical Medicine
关键词 分化型甲状腺癌 手术 应用效果 Differentiated thyroid carcinoma Surgery Application effect
  • 相关文献

参考文献7

二级参考文献87

  • 1Phan HT, Jager PL, van der Wal JE, et al. The follow-up of patients with differentiated thyroid cancer and undetectable thyreglobulin(Tg) and Tg antibodies during ablation. Eur J Endocrinol, 2008, 158: 77 -83.
  • 2Derey TW,Paul GG. Role of 1311 in the treatment of well differentiated thyroid cancer. J Gurg Onco1,2005,89 : 114-121.
  • 3Kouvaraki MA, Shapiro SE, Lee JE, et al. Surgical management of thy- roid carcinoma. J Natl Compr Canc Netw,2005,3:458-466.
  • 4Mazzaferri EL, Kloos RT. Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endo- crinol Metab ,2001,86 : 1447-1453.
  • 5Hay ID, Thompson GB, Grant CS, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999 ) :Tempo- ral trends in initial therapy and long-term outcome in 2444 consecu- tively treated patients. World J Surg,2002,26:879-885.
  • 6Carlisle MR, Lu C, McDougall IR. The interpretation of i311 scans in the evaluation of thyroid cancer, with an emphasis on false positive findings. Nucl Med Commun, 2003,24:715-735.
  • 7Leitha T, Staudenherz A. Frequency of diagnostic dilemmas in 131I whole body scanning. Nuklearmedizin,2003 ,42 :55-62.
  • 8Ma C, Kuang A, Xie J, et al. Possible explanations for patients with discordant findings of serum thyroglobulin and 131I whole-body scan- ning. J Nucl Med, 2005,46 : 1473-1480.
  • 9Mitchell G, Pratt BE, Vini L, et al. False positive 131I whole body scans in thyroid cancer. Br J Radiol,2000,73:627-635.
  • 10Tharp K,Israel O,Hausmann J,et al. Impact of xslI-SPECT/CT ima- ges obtained with an integrated system in the follow-up of patients with thyroid carcinoma. Eur J Nuel Med Mol Imaging, 2004, 31: 1435 -1442.

共引文献41

同被引文献34

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部